Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

Novara Giacomo; Chapple Christopher R.; Montorsi Francesco

首页> 外文期刊>BJU international >Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

【24h】

Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

机译：西洛多辛治疗非良性前列腺增生（BPH）的非神经源性男性下尿路症状（LUTS）的注册试验中的个别患者数据：有效性和安全性数据的亚组分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：目的

著录项

来源
《BJU international》 |2015年第5期|共13页
作者
Novara Giacomo; Chapple Christopher R.; Montorsi Francesco;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词
benign prostatic hyperplasia (BPH); lower urinary tract symptoms (LUTS); silodosin; alpha-blockers;

机译：前列腺增生（BPH）;下尿路症状（LUTS）;西洛多辛;α受体阻滞剂;

相似文献

外文文献
中文文献
专利

1. Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data [J] . Novara Giacomo, Chapple Christopher R., Montorsi Francesco BJU international . 2015,第5期

机译：西洛多辛治疗非良性前列腺增生（BPH）的非神经源性男性下尿路症状（LUTS）的注册试验中的个别患者数据：有效性和安全性数据的亚组分析
2. Efficacy and safety of a hexanic extract of Serenoa repens Serenoa repens (Permixon ? ? ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia ( LUTS LUTS / BPH BPH ): systematic review and meta‐analysis of randomised controlled trials and observational studies [J] . Vela‐Navarrete Remigio, Alcaraz Antonio, Rodríguez‐Antolín Alfredo, BJU international . 2018,第6期

机译：乳头塞塞蛋白塞蛋白塞（Permixon？）治疗与良性前列腺增生（LUTS LUTS / BPH）相关的治疗疗效和安全性的疗效和安全性：随机对照试验和观察的系统评价和荟萃分析学习
3. Comparative efficacy and safety profile of 4 vs 8?mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity [J] . Abdullah Gul, Soner Coban, Ali Riza Turkoglu, Prostate International . 2020,第4期

机译：比较疗效和安全性曲线为4毫克硅霉素均每日使用良性前列腺增生患者患者与国际前列腺症状评分严重程度分为亚组
4. New Surgical Treatment Options in Patients with Benign Prostate Hyperplasia (BPH) [C] . Werner T.W. de Riese, Thomas Nelius, David R. Aronoff, Conference on lasers in surgery: Advanced characterization, therapeutics, and systems . 2003

机译：良性前列腺增生（BPH）患者的新手术治疗方案
5. Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity [O] . Abdullah Gul, Soner Coban, Ali Riza Turkoglu, 2020

机译：比较疗效和安全曲线为4毫克8毫克的硅延蛋白每日使用良性前列腺增生患者与良性前列腺增生相关的低尿路症状分为亚组根据国际前列腺症状得分严重程度
6. Erratum to: Systematic review and meta-analysis of randomized controlled trials evaluating silodosin in the treatment of non-neurogenic male lower urinary tract symptoms suggestive of benign prostatic enlargement (World J Urol, 10.1007/s00345-012-0944-8) [O] . G. Novara, A. Tubaro, R. Sanseverino, 2013

机译：勘误至：评价西洛多辛治疗提示非良性前列腺增生的非神经源性男性下尿路症状的随机对照试验的系统评价和荟萃分析（World J Urol，10.1007 / s00345-012-0944-8）

Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): subgroup analyses of efficacy and safety data

摘要

著录项

相似文献

相关主题

期刊订阅